OPKO Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hi, everyone. Good afternoon. Thank you all for joining us today for our conversation with OPKO Health. My name is Adi Jayanthi from the JPMorgan's Healthcare Investment Banking team. I'm really excited today to introduce the management team at OPKO Health.
So with us today, we have Dr. Phil Frost, CEO and Chairman of OPKO; Steve Rubin, Executive Vice President, Administration; Adam Logal, Senior Vice President and CFO; Jon Cohen, Senior Vice President of OPKO and Executive Chairman of BioReference Laboratories; and Katherine Stueland, President and CEO of GeneDx. So welcome to all of you and thank you very much for joining us here at the conference.
Maybe before we get going, obviously, you guys are a diversified business and would love to just get an overview of the company and any particular areas that you'd like to highlight.
Sure. So I'll give you a little brief overview for the BioReference piece
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
